222 related articles for article (PubMed ID: 24201225)
1. Interphase microtubules: chief casualties in the war on cancer?
Ogden A; Rida PC; Reid MD; Aneja R
Drug Discov Today; 2014 Jul; 19(7):824-9. PubMed ID: 24201225
[TBL] [Abstract][Full Text] [Related]
2. Mitosis is not a key target of microtubule agents in patient tumors.
Komlodi-Pasztor E; Sackett D; Wilkerson J; Fojo T
Nat Rev Clin Oncol; 2011 Feb; 8(4):244-50. PubMed ID: 21283127
[TBL] [Abstract][Full Text] [Related]
3. A new perspective on old drugs: non-mitotic actions of tubulin-binding drugs play a major role in cancer treatment.
Fürst R; Vollmar AM
Pharmazie; 2013 Jul; 68(7):478-83. PubMed ID: 23923626
[TBL] [Abstract][Full Text] [Related]
4. The microtubule targeting agent ST-401 triggers cell death in interphase and prevents the formation of polyploid giant cancer cells.
Vicente JJ; Khan K; Tillinghast G; McFaline-Figueroa JL; Sancak Y; Stella N
J Transl Med; 2024 May; 22(1):441. PubMed ID: 38730481
[TBL] [Abstract][Full Text] [Related]
5. Microtubule-targeting agents and their impact on cancer treatment.
Čermák V; Dostál V; Jelínek M; Libusová L; Kovář J; Rösel D; Brábek J
Eur J Cell Biol; 2020 May; 99(4):151075. PubMed ID: 32414588
[TBL] [Abstract][Full Text] [Related]
6. Microtubule-targeting agents are clinically successful due to both mitotic and interphase impairment of microtubule function.
Field JJ; Kanakkanthara A; Miller JH
Bioorg Med Chem; 2014 Sep; 22(18):5050-9. PubMed ID: 24650703
[TBL] [Abstract][Full Text] [Related]
7. Contrasting effects of microtubule destabilizers versus stabilizers on induction of death in G1 phase of the cell cycle.
Delgado M; Urbaniak A; Chambers TC
Biochem Pharmacol; 2019 Apr; 162():213-223. PubMed ID: 30578765
[TBL] [Abstract][Full Text] [Related]
8. Microtubule-targeted agents: when mitochondria become essential to chemotherapy.
Rovini A; Savry A; Braguer D; Carré M
Biochim Biophys Acta; 2011 Jun; 1807(6):679-88. PubMed ID: 21216222
[TBL] [Abstract][Full Text] [Related]
9. Die-hard survivors: heterogeneity in apoptotic thresholds may underlie chemoresistance.
Ogden A; Rida PC; Reid MD; Kucuk O; Aneja R
Expert Rev Anticancer Ther; 2015 Mar; 15(3):277-81. PubMed ID: 25695344
[TBL] [Abstract][Full Text] [Related]
10. Small molecules targeted to the microtubule-Hec1 interaction inhibit cancer cell growth through microtubule stabilization.
Ferrara M; Sessa G; Fiore M; Bernard F; Asteriti IA; Cundari E; Colotti G; Ferla S; Desideri M; Buglioni S; Trisciuoglio D; Del Bufalo D; Brancale A; Degrassi F
Oncogene; 2018 Jan; 37(2):231-240. PubMed ID: 28925395
[TBL] [Abstract][Full Text] [Related]
11. Microtubule-targeting agents augment the toxicity of DNA-damaging agents by disrupting intracellular trafficking of DNA repair proteins.
Poruchynsky MS; Komlodi-Pasztor E; Trostel S; Wilkerson J; Regairaz M; Pommier Y; Zhang X; Kumar Maity T; Robey R; Burotto M; Sackett D; Guha U; Fojo AT
Proc Natl Acad Sci U S A; 2015 Feb; 112(5):1571-6. PubMed ID: 25605897
[TBL] [Abstract][Full Text] [Related]
12. Targeting microtubules by natural agents for cancer therapy.
Mukhtar E; Adhami VM; Mukhtar H
Mol Cancer Ther; 2014 Feb; 13(2):275-84. PubMed ID: 24435445
[TBL] [Abstract][Full Text] [Related]
13. Microtubule-targeting agents can sensitize cancer cells to ionizing radiation by an interphase-based mechanism.
Markowitz D; Ha G; Ruggieri R; Symons M
Onco Targets Ther; 2017; 10():5633-5642. PubMed ID: 29200877
[TBL] [Abstract][Full Text] [Related]
14. Cell Cycle-Dependent Mechanisms Underlie Vincristine-Induced Death of Primary Acute Lymphoblastic Leukemia Cells.
Kothari A; Hittelman WN; Chambers TC
Cancer Res; 2016 Jun; 76(12):3553-61. PubMed ID: 27197148
[TBL] [Abstract][Full Text] [Related]
15. Regulating the BCL2 Family to Improve Sensitivity to Microtubule Targeting Agents.
Whitaker RH; Placzek WJ
Cells; 2019 Apr; 8(4):. PubMed ID: 31013740
[TBL] [Abstract][Full Text] [Related]
16. Membrane-bound TNF mediates microtubule-targeting chemotherapeutics-induced cancer cytolysis via juxtacrine inter-cancer-cell death signaling.
Zhang J; Yang Y; Zhou S; He X; Cao X; Wu C; Hu H; Qin J; Wei G; Wang H; Liu S; Sun L
Cell Death Differ; 2020 May; 27(5):1569-1587. PubMed ID: 31645676
[TBL] [Abstract][Full Text] [Related]
17. Microtubule Targeting Agents in Disease: Classic Drugs, Novel Roles.
Wordeman L; Vicente JJ
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830812
[TBL] [Abstract][Full Text] [Related]
18. Mitosis inhibitors in anticancer therapy: When blocking the exit becomes a solution.
Henriques AC; Ribeiro D; Pedrosa J; Sarmento B; Silva PMA; Bousbaa H
Cancer Lett; 2019 Jan; 440-441():64-81. PubMed ID: 30312726
[TBL] [Abstract][Full Text] [Related]
19. Interactome Analysis of Microtubule-targeting Agents Reveals Cytotoxicity Bases in Normal Cells.
Gutiérrez-Escobar AJ; Méndez-Callejas G
Genomics Proteomics Bioinformatics; 2017 Dec; 15(6):352-360. PubMed ID: 29246518
[TBL] [Abstract][Full Text] [Related]
20. An overview of microtubule targeting agents for cancer therapy.
Karahalil B; Yardım-Akaydin S; Nacak Baytas S
Arh Hig Rada Toksikol; 2019 Sep; 70(3):160-172. PubMed ID: 32597128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
